AI-enabled symptom checker Infermedica has raised $10.25 million in Series A funding. Infermedica says the new funds will be used for research and development to
AI-enabled symptom checker Infermedica has raised $10.25 million in Series A funding. Infermedica says the new funds will be used for research and development to